References
- Allam JP, Novak N. The pathophysiology of atopic eczema. Clin Exp Dermatol. 2006. 31: 89-93. https://doi.org/10.1111/j.1365-2230.2005.01980.x
- Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, Fernandes-Alnemri T, Wu J, Monks BG, Fitzgerald KA, Hornung V, Latz E. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009. 183: 787-791. https://doi.org/10.4049/jimmunol.0901363
- Boero S, Silvestri M, Ullmann N, Rossi GA. Modulation by flunisolide of tumor necrosis factor-alpha-induced stimulation of airway epithelial cell activities related to eosinophil inflammation. J Asthma. 2010. 47: 381-387. https://doi.org/10.3109/02770901003759410
- Brenninkmeijer EE, Spuls PI, Legierse CM, Lindeboom R, Smitt JH, Bos JD. Clinical differences between atopic and atopiform dermatitis. J Am Acad Dermatol. 2008. 58: 407-414. https://doi.org/10.1016/j.jaad.2007.12.002
- Buske-Kirschbaum A, Geiben A, Hellhammer D. Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom. 2001. 70: 6-16. https://doi.org/10.1159/000056219
- Druilhe A, Srinivasula SM, Razmara M, Ahmad M, Alnemri ES. Regulation of IL-1beta generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Differ. 2001. 8: 649-657. https://doi.org/10.1038/sj.cdd.4400881
- Faubel S, Lewis EC, Reznikov L, Ljubanovic D, Hoke TS, Somerset H, Oh DJ, Lu L, Klein CL, Dinarello CA, Edelstein CL. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J Pharmacol Exp Ther. 2007. 322: 8-15. https://doi.org/10.1124/jpet.107.119792
- Gadaleta RM, Oldenburg B, Willemsen EC, Spit M, Murzilli S, Salvatore L, Klomp LW, Siersema PD, van Erpecum KJ, van Mil SW. Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-_{\kappa}B signaling in the intestine. Biochim Biophys Acta. 2011. 1812: 851-858. https://doi.org/10.1016/j.bbadis.2011.04.005
-
Gilmore TD, Garbati MR. Inhibition of NF-
${\kappa}B$ signaling as a strategy in disease therapy. Curr Top Microbiol Immunol. 2011. 349: 245-263. - Gold MS, Kemp AS. Atopic disease in childhood. Med J Aust. 2005. 182: 298-304.
- Humke EW, Shriver SK, Starovasnik MA, Fairbrother WJ, Dixit VM. ICEBERG: a novel inhibitor of interleukin-1beta generation. Cell. 2000. 103: 99-111. https://doi.org/10.1016/S0092-8674(00)00108-2
- Kim SJ, Chung WS, Kim SS, Ko SG, Um JY. Antiinflammatory effect of Oldenlandia diffusa and its constituent, hentriacontane, through suppression of caspase-1 activation in mouse peritoneal macrophages. Phytother Res. 2011. 25: 1537-1546. https://doi.org/10.1002/ptr.3443
- Lee SH, Stehlik C, Reed JC. Cop, a caspase recruitment domaincontaining protein and inhibitor of caspase-1 activation processing. J Biol Chem. 2001. 276: 34495-34500. https://doi.org/10.1074/jbc.M101415200
- Leung DY, Bieber T. Atopic dermatitis. Lancet. 2003. 361: 151-160. https://doi.org/10.1016/S0140-6736(03)12193-9
- McCormick TS, Stevens SR, Kang K. Macrophages and cutaneous inflammation. Nat Biotechnol. 2000. 18: 25-26. https://doi.org/10.1038/71879
- Minami K, Kamei C. A chronic model for evaluating the itching associated with allergic conjunctivitis in rats. Int Immunopharmacol. 2004. 4: 101-108. https://doi.org/10.1016/j.intimp.2003.10.013
- Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol. 2000. 72: 391-398.
- Shiohara T, Hayakawa J, Mizukawa Y. Animal models for atopic dermatitis: are they relevant to human disease? J Dermatol Sci. 2004. 36: 1-9. https://doi.org/10.1016/j.jdermsci.2004.02.013
- Taxman DJ, Holley-Guthrie EA, Huang MT, Moore CB, Bergstralh DT, Allen IC, Lei Y, Gris D, Ting JP. The NLR adaptor ASC/ PYCARD regulates DUSP10, mitogen-activated protein kinase (MAPK), and chemokine induction independent of the inflammasome. J Biol Chem. 2011. 286: 19605-19616. https://doi.org/10.1074/jbc.M111.221077
- Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenaseindependent actions of cyclooxygenase inhibitors. FASEB J. 2001. 15: 2057-2072. https://doi.org/10.1096/fj.01-0390rev
- Trefzer U, Hofmann M, Sterry W, Asadullah K. Cytokine and anticytokine therapy in dermatology. Expert Opin Biol Ther. 2003. 3: 733-743. https://doi.org/10.1517/14712598.3.5.733
- Wang X, Wang H, Figueroa BE, Zhang WH, Huo C, Guan Y, Zhang Y, Bruey JM, Reed JC, Friedlander RM. Dysregulation of receptor interacting protein-2 and caspase recruitmentdomain only protein mediates aberrant caspase-1 activation in Huntington's disease. J Neurosci. 2005. 25: 11645-11654. https://doi.org/10.1523/JNEUROSCI.4181-05.2005